As of 2026-09-15, the Relative Valuation of Syros Pharmaceuticals Inc (SYRS) is (22,002.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 USD, the upside of Syros Pharmaceuticals Inc based on Relative Valuation is -18773872.1%.
The range of the Relative Valuation is (20,507.52) - (25,207.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 23.6x | 21.4x |
| Forward P/E multiples | 15.9x - 23.7x | 19.8x |
| Fair Price | (20,507.52) - (25,207.16) | (22,002.86) |
| Upside | -17497984.7% - -21507916.6% | -18773872.1% |
| Date | P/E |
| 2026-09-04 | -0.00 |
| 2026-09-03 | -0.00 |
| 2026-09-02 | -0.00 |
| 2026-09-01 | -0.00 |
| 2026-08-31 | -0.00 |
| 2026-08-28 | -0.00 |
| 2026-08-27 | -0.00 |
| 2026-08-26 | -0.00 |
| 2026-08-25 | -0.00 |
| 2026-08-24 | -0.00 |
| 2026-08-21 | -0.00 |
| 2026-08-20 | -0.00 |
| 2026-08-19 | -0.00 |
| 2026-08-18 | -0.00 |
| 2026-08-17 | -0.00 |
| 2026-08-14 | -0.00 |
| 2026-08-13 | -0.00 |
| 2026-08-12 | -0.00 |
| 2026-08-11 | -0.00 |
| 2026-08-10 | -0.00 |
| 2026-08-07 | -0.00 |
| 2026-08-06 | -0.00 |
| 2026-08-05 | -0.00 |
| 2026-08-04 | -0.00 |
| 2026-08-03 | -0.00 |
| 2026-07-30 | -0.00 |
| 2026-07-29 | -0.00 |
| 2026-07-28 | -0.00 |
| 2026-07-24 | -0.00 |
| 2026-07-23 | -0.00 |
| 2026-07-22 | -0.00 |
| 2026-07-21 | -0.00 |
| 2026-07-20 | -0.00 |
| 2026-07-17 | -0.00 |
| 2026-07-16 | -0.00 |
| 2026-07-15 | -0.00 |
| 2026-07-14 | -0.00 |
| 2026-07-13 | -0.00 |
| 2026-07-10 | -0.00 |
| 2026-07-09 | -0.00 |
| 2026-07-08 | -0.00 |
| 2026-07-07 | -0.00 |
| 2026-07-06 | -0.00 |
| 2026-07-02 | -0.00 |
| 2026-07-01 | -0.00 |
| 2026-06-30 | -0.00 |
| 2026-06-29 | -0.00 |
| 2026-06-26 | -0.00 |
| 2026-06-25 | -0.00 |
| 2026-06-24 | -0.00 |